Skip to content
Sub practice
Sub practice

Leveraged Finance

We are one of the leading Leveraged Finance practices in the world, known for ground-breaking deals and structures that eventually become market standards.

Thanks to our network, we can combine a multi-jurisdictional leveraged debt team with an extensive capital markets practice.

This enables us to provide our clients with a full service for senior, second-lien, mezzanine and PIK debt, bridge-to-bond financings, bank/bond financings, high-yield debt offerings, securitisation take-outs and debt buy-backs and restructurings.

Our sector knowledge and understanding of our clients’ business objectives enables us to provide legal advice that truly meets those aims within the context of the overall rationale for the debt package. Lenders and borrowers alike need to be able to structure deals in ways that suit market conditions. Our lawyers can advise on any form of leveraged financing that our clients choose to undertake.

The leveraged finance market has changed. Deals these days are different and structuring them demands a broad mix of finance capabilities. We combine our market-leading practices in banking and leveraged finance with a pre-eminent high yield practice. This makes us one of the very few law firms that has the ability to cover all aspects of complicated leveraged finance and high yield transactions and crossover and emerging markets high yield transactions.

 
 

News and insights

wind turbines

News: 21 March 2024

Allen & Overy advises arrangers on takeover of Encavis by KKR

Allen & Overy has advised arrangers in connection with the planned takeover of Hamburg-based wind farm and solar park operator ENCAVIS AG ("Encavis") by Elbe BidCo AG, a holding company controlled by…

Read more
Aerial view of a spiralling road network

News: 13 February 2024

A&O advises on establishment of notes shelf agreement and issuance of Series A Notes by John Laing

Allen & Overy has advised MetLife Investment Management and certain of its affiliates and managed accounts on the establishment of a note purchase and private shelf agreement with John Laing Group…

Read more
Glass test tubes in a tray

News: 09 February 2024

Allen & Overy advises Exponent on investment in Chanelle Pharma

LONDON – Allen & Overy (A&O) has advised Exponent Private Equity LLP (Exponent), a leading European private equity firm, on its investment in Ireland's largest manufacturer of generic pharmaceuticals,…

Read more
Highway intersection lit up at night

Publications: 05 October 2023

Creative exit strategies drive higher returns for sponsors

With dual-tracks largely off the menu for the time being, we explore the risks and opportunities inherent in alternative exit strategies, including synthetic IPOs and sales with ‘stapled’ debt. 

Read more

Recognition